GNOM Stock Global X Genomics & Biotechnology ETF (GNOM) (GNOM, $67.6) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 21, 2026
at Tickeron.com
This is a Bullish indicator signaling GNOM's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 54 similar cases where GNOM's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:
Momentum Indicator for GNOM turns positive, indicating new upward trend
GNOM saw its Momentum Indicator move above the 0 level on September 17, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 103 similar instances where the indicator turned positive. In 95 of the 103 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for GNOM just turned positive on September 21, 2026. Looking at past instances where GNOM's MACD turned positive, the stock continued to rise in 50 of 55 cases over the following month. The odds of a continued upward trend are 90%.
Following a +4.34% 3-day Advance, the price is estimated to grow further. Considering data from situations where GNOM advanced for three days, in 221 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Aroon Indicator entered an Uptrend today. In 162 of 187 cases where GNOM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.
Bearish Trend Analysis
The 10-day RSI Indicator for GNOM moved out of overbought territory on September 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 25 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNOM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
GNOM broke above its upper Bollinger Band on September 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.